Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Drug Administration Schedule"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 380
Tytuł:
Does once-daily dosing prevent nephrotoxicity in all aminoglycosides equally?
Autorzy:
Beaucaire G; Intensive Care and Infectious Diseases Unit, G. Dron Hospital, Tourcoing, France.
Pokaż więcej
Źródło:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2000 Jul; Vol. 6 (7), pp. 357-62.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Anti-Bacterial Agents*/administration & dosage
Anti-Bacterial Agents*/adverse effects
Anti-Bacterial Agents*/metabolism
Drug Administration Schedule*
Kidney/*metabolism
Kidney Diseases/*chemically induced
Aminoglycosides ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Abordaje terapéutico de la otitis media aguda en atención primaria de un área urbana. Evaluación de la prescripción diferida de antibióticos
Autorzy:
María García Ventura
César García Vera
Juan Ruiz-Canela Cáceres
Pokaż więcej
Temat:
Acute otitis media
Administration and dosage of antibacterial agents
Antimicrobial stewardship
Drug administration schedule
Child
Pediatrics
RJ1-570
Źródło:
Anales de Pediatría, Vol 96, Iss 5, Pp 422-430 (2022)
Opis pliku:
electronic resource
Relacje:
http://www.sciencedirect.com/science/article/pii/S1695403321000138; https://doaj.org/toc/1695-4033
Dostęp URL:
https://doaj.org/article/b0869ac80ba24884aa288f57e7812834  Link otwiera się w nowym oknie
Czasopismo naukowe
Szczegóły
Tytuł:
Voriconazole concentrations and outcome of invasive fungal infections.
Autorzy:
Miyakis S; Department of Microbiology and Infectious Diseases, New South Wales Referral Laboratory for Therapeutic Drug Monitoring, St Vincent's Hospital, Sydney, NSW, Australia.
van Hal SJ
Ray J
Marriott D
Pokaż więcej
Źródło:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2010 Jul; Vol. 16 (7), pp. 927-33. Date of Electronic Publication: 2009 Oct 20.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Monitoring*
Antifungal Agents/*blood
Mycoses/*drug therapy
Pyrimidines/*blood
Triazoles/*blood
Adult ; Aged ; Antifungal Agents/adverse effects ; Antifungal Agents/therapeutic use ; Australia ; Chromatography, High Pressure Liquid ; Drug Administration Schedule ; Female ; Humans ; Immunosuppression Therapy ; Male ; Middle Aged ; Mycoses/blood ; Mycoses/epidemiology ; Mycoses/immunology ; Pyrimidines/adverse effects ; Pyrimidines/therapeutic use ; Treatment Outcome ; Triazoles/adverse effects ; Triazoles/therapeutic use ; Voriconazole ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Cost-effectiveness of scheduled maintenance treatment with infliximab for pediatric Crohn's disease.
Autorzy:
Punekar YS; Schering-Plough Ltd., Hertfordshire, UK. />Sunderland T
Hawkins N
Lindsay J
Pokaż więcej
Źródło:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2010 Mar-Apr; Vol. 13 (2), pp. 188-95. Date of Electronic Publication: 2009 Oct 26.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Anti-Inflammatory Agents/*administration & dosage
Anti-Inflammatory Agents/*economics
Antibodies, Monoclonal/*administration & dosage
Antibodies, Monoclonal/*economics
Crohn Disease/*drug therapy
Crohn Disease/*economics
Child ; Cost-Benefit Analysis ; Drug Administration Schedule ; Humans ; Infliximab ; Markov Chains ; Quality-Adjusted Life Years ; State Medicine ; Treatment Outcome ; United Kingdom
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Phase I study of paclitaxel, cisplatin and 5-fluorouracil combination chemotherapy for unresectable / recurrent gastric cancer.
Autorzy:
Kato J; Department of Gastroenterology, Juntendo University School of Medicine, Tokyo, Japan. />Nagahara A
Iijima K
Kodani T
Higashihara Y
Yoshimura M
Serizawa N
Osada T
Yoshizawa T
Otaka M
Watanabe S
Pokaż więcej
Źródło:
Advances in medical sciences [Adv Med Sci] 2010; Vol. 55 (2), pp. 137-42.
Typ publikacji:
Clinical Trial, Phase I; Journal Article
MeSH Terms:
Antineoplastic Agents/*therapeutic use
Cisplatin/*therapeutic use
Fluorouracil/*therapeutic use
Paclitaxel/*therapeutic use
Stomach Neoplasms/*drug therapy
Aged ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Drug Administration Schedule ; Female ; Humans ; Male ; Middle Aged
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Consistent bone marrow-derived cell mobilization following repeated short courses of granulocyte-colony-stimulating factor in patients with amyotrophic lateral sclerosis: results from a multicenter prospective trial.
Autorzy:
Tarella C; Dip Medicina-Oncologia Sperimentale, SC Universitaria di Ematologia and Molecular Biotechnology Center, Torino, Italy. />Rutella S
Gualandi F
Melazzini M
Scimè R
Petrini M
Moglia C
Ulla M
Omedé P
Bella VL
Corbo M
Silani V
Siciliano G
Mora G
Caponnetto C
Sabatelli M
Chiò A
Pokaż więcej
Corporate Authors:
STEMALS STUDY GROUP
Źródło:
Cytotherapy [Cytotherapy] 2010; Vol. 12 (1), pp. 50-9.
Typ publikacji:
Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Hematopoietic Stem Cell Mobilization*
Amyotrophic Lateral Sclerosis/*drug therapy
Bone Marrow Cells/*drug effects
Cell Movement/*drug effects
Granulocyte-Macrophage Colony-Stimulating Factor/*administration & dosage
Hematopoietic Stem Cells/*drug effects
Adult ; Amyotrophic Lateral Sclerosis/physiopathology ; Antigens, CD34/metabolism ; Biomarkers/metabolism ; Bone Marrow Cells/physiology ; Cell Differentiation/drug effects ; Cell Differentiation/physiology ; Cell Lineage/drug effects ; Cell Lineage/physiology ; Cell Movement/physiology ; Colony-Forming Units Assay ; Drug Administration Schedule ; Female ; Hematopoietic Stem Cells/physiology ; Humans ; Male ; Middle Aged ; Nerve Regeneration/drug effects ; Nerve Regeneration/physiology ; Neuroglia/cytology ; Neuroglia/physiology ; Neurons/cytology ; Neurons/physiology ; Prospective Studies ; Stem Cells/drug effects ; Stem Cells/physiology ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Single-dose extended-release oral azithromycin vs. 3-day azithromycin for the treatment of group A beta-haemolytic streptococcal pharyngitis/tonsillitis in adults and adolescents: a double-blind, double-dummy study.
Autorzy:
Jorgensen DM; Pfizer Inc, New London, CT 06320, USA.
Pokaż więcej
Źródło:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2009 Dec; Vol. 15 (12), pp. 1103-10.
Typ publikacji:
Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Anti-Bacterial Agents/*administration & dosage
Azithromycin/*administration & dosage
Pharyngitis/*drug therapy
Streptococcus pyogenes/*drug effects
Tonsillitis/*drug therapy
Administration, Oral ; Adolescent ; Adult ; Aged ; Anti-Bacterial Agents/therapeutic use ; Azithromycin/therapeutic use ; Delayed-Action Preparations ; Dose-Response Relationship, Drug ; Double-Blind Method ; Drug Administration Schedule ; Female ; Humans ; Male ; Middle Aged ; Pharyngitis/microbiology ; Streptococcal Infections/drug therapy ; Streptococcal Infections/microbiology ; Tonsillitis/microbiology ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Effect of different gonadotrophin priming on IVM of oocytes from women with normal ovaries: a prospective randomized study.
Autorzy:
Fadini R; Biogenesi Reproductive Medicine Centre, Istituti Clinici Zucchi, V Zucchi, 24-Monza, Italy.
Dal Canto MB
Mignini Renzini M
Brambillasca F
Comi R
Fumagalli D
Lain M
Merola M
Milani R
De Ponti E
Pokaż więcej
Źródło:
Reproductive biomedicine online [Reprod Biomed Online] 2009 Sep; Vol. 19 (3), pp. 343-51.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Gonadotropins/*administration & dosage
Oocytes/*drug effects
Oogenesis/*drug effects
Ovary/*drug effects
Adult ; Cells, Cultured ; Chorionic Gonadotropin/administration & dosage ; Drug Administration Schedule ; Drug Combinations ; Embryo Implantation/drug effects ; Embryo Implantation/physiology ; Embryo Transfer ; Embryonic Development/drug effects ; Female ; Fertility Agents, Female/administration & dosage ; Follicle Stimulating Hormone/administration & dosage ; Health ; Humans ; Oocytes/cytology ; Oocytes/physiology ; Oogenesis/physiology ; Ovary/physiology ; Pregnancy ; Pregnancy Rate
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Patient-reported outcomes and health-care resource utilization in patients with psoriasis treated with etanercept: continuous versus interrupted treatment.
Autorzy:
Gelfand JM; Department of Dermatology and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA.
Kimball AB
Mostow EN
Chiou CF
Patel V
Xia HA
Freundlich B
Stevens SR
Pokaż więcej
Źródło:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2008 May-Jun; Vol. 11 (3), pp. 400-7.
Typ publikacji:
Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Outcome Assessment, Health Care*
Health Resources/*statistics & numerical data
Immunoglobulin G/*therapeutic use
Immunosuppressive Agents/*therapeutic use
Psoriasis/*drug therapy
Receptors, Tumor Necrosis Factor/*therapeutic use
Drug Administration Schedule ; Etanercept ; Female ; Humans ; Immunoglobulin G/administration & dosage ; Immunoglobulin G/economics ; Immunosuppressive Agents/administration & dosage ; Immunosuppressive Agents/economics ; Male ; Patient Satisfaction ; Quality of Life ; Receptors, Tumor Necrosis Factor/administration & dosage ; Self Disclosure ; Surveys and Questionnaires
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
An Asian regional analysis of cost-effectiveness of early irbesartan treatment versus conventional antihypertensive, late amlodipine, and late irbesartan treatments in patients with type 2 diabetes, hypertension, and nephropathy.
Autorzy:
Annemans L; Ghent University and IMS Health, Bruxelles, Belgium, and IMS Health, Bruxelles, Belgium.
Demarteau N
Hu S
Lee TJ
Morad Z
Supaporn T
Yang WC
Palmer AJ
Pokaż więcej
Źródło:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2008 May-Jun; Vol. 11 (3), pp. 354-64. Date of Electronic Publication: 2007 Sep 21.
Typ publikacji:
Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Amlodipine/*economics
Antihypertensive Agents/*economics
Biphenyl Compounds/*economics
Diabetes Mellitus, Type 2/*drug therapy
Diabetic Neuropathies/*drug therapy
Hypertension/*drug therapy
Tetrazoles/*economics
Amlodipine/administration & dosage ; Antihypertensive Agents/administration & dosage ; Asia ; Biphenyl Compounds/administration & dosage ; Cost-Benefit Analysis ; Diabetes Mellitus, Type 2/economics ; Diabetic Neuropathies/economics ; Drug Administration Schedule ; Humans ; Hypertension/economics ; Irbesartan ; Models, Econometric ; Tetrazoles/administration & dosage ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Duration of antipsychotic drug therapy in real-world practice: a comparison with CATIE trial results.
Autorzy:
Chen L; Department of Pharmaceutical Economics and Policy, School of Pharmacy, University of Southern California, Los Angeles, CA, USA.
McCombs JS
Park J
Pokaż więcej
Źródło:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2008 May-Jun; Vol. 11 (3), pp. 487-96.
Typ publikacji:
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antipsychotic Agents/*administration & dosage
Schizophrenia/*drug therapy
Adult ; Clinical Trials as Topic ; Drug Administration Schedule ; Drug Utilization Review ; Female ; Humans ; Least-Squares Analysis ; Male ; Proportional Hazards Models ; Time Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The contribution of pharmacokinetic-pharmacodynamic modelling with Monte Carlo simulation to the development of susceptibility breakpoints for Neisseria meningitidis.
Autorzy:
Burgess DS; College of Pharmacy, The University of Texas at Austin, Austin, Texas, USA. />Frei CR
Lewis Ii JS
Fiebelkorn KR
Jorgensen JH
Pokaż więcej
Źródło:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2007 Jan; Vol. 13 (1), pp. 33-9.
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Computer Simulation*
Monte Carlo Method*
Anti-Infective Agents/*administration & dosage
Anti-Infective Agents/*pharmacology
Meningococcal Infections/*drug therapy
Neisseria meningitidis/*drug effects
Animals ; Anti-Infective Agents/cerebrospinal fluid ; Anti-Infective Agents/pharmacokinetics ; Drug Administration Schedule ; Humans ; Microbial Sensitivity Tests
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial.
Autorzy:
MacArthur RD; Wayne State University, Detroit, MI, USA. />Novak RM
Peng G
Chen L
Xiang Y
Hullsiek KH
Kozal MJ
van den Berg-Wolf M
Henely C
Schmetter B
Dehlinger M
Pokaż więcej
Corporate Authors:
CPCRA 058 Study Team
Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA)
Źródło:
Lancet (London, England) [Lancet] 2006 Dec 16; Vol. 368 (9553), pp. 2125-35.
Typ publikacji:
Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
MeSH Terms:
Antiretroviral Therapy, Highly Active*
HIV Infections/*drug therapy
HIV Protease Inhibitors/*therapeutic use
Reverse Transcriptase Inhibitors/*therapeutic use
Adult ; Analysis of Variance ; CD4 Lymphocyte Count ; Drug Administration Schedule ; Female ; Follow-Up Studies ; HIV Infections/blood ; HIV Infections/mortality ; HIV Protease Inhibitors/administration & dosage ; HIV Protease Inhibitors/adverse effects ; Humans ; Kaplan-Meier Estimate ; Male ; Reverse Transcriptase Inhibitors/administration & dosage ; Reverse Transcriptase Inhibitors/adverse effects ; United States ; Viral Load
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Pralidoxime for organophosphate poisoning.
Autorzy:
Eyer P; Walther-Straub-Institute of Pharmacology and Toxicology, University of Munich, Munich D-80336, Germany. />Buckley N
Pokaż więcej
Źródło:
Lancet (London, England) [Lancet] 2006 Dec 16; Vol. 368 (9553), pp. 2110-1.
Typ publikacji:
Comment; Journal Article
MeSH Terms:
Organophosphate Poisoning*
Cholinesterase Reactivators/*therapeutic use
Insecticides/*poisoning
Pralidoxime Compounds/*therapeutic use
Cholinesterase Reactivators/administration & dosage ; Cholinesterase Reactivators/blood ; Drug Administration Schedule ; Humans ; Infusions, Intravenous ; Pralidoxime Compounds/administration & dosage ; Pralidoxime Compounds/blood ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Initial strategy for antiretroviral-naive patients.
Autorzy:
Abgrall S; Department of Infectious and Tropical Diseases, Avicenne Hospital, 93 000 Bobigny, France.
Pokaż więcej
Źródło:
Lancet (London, England) [Lancet] 2006 Dec 16; Vol. 368 (9553), pp. 2107-9.
Typ publikacji:
Comment; Comparative Study; Journal Article
MeSH Terms:
Antiretroviral Therapy, Highly Active/*methods
HIV Infections/*drug therapy
HIV Protease Inhibitors/*administration & dosage
Reverse Transcriptase Inhibitors/*administration & dosage
CD4 Lymphocyte Count ; Drug Administration Schedule ; HIV Infections/immunology ; Humans ; Randomized Controlled Trials as Topic ; Treatment Failure
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes.
Autorzy:
Drucker DJ; Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada. />Nauck MA
Pokaż więcej
Źródło:
Lancet (London, England) [Lancet] 2006 Nov 11; Vol. 368 (9548), pp. 1696-705.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Adenosine Deaminase Inhibitors*
Dipeptidyl-Peptidase IV Inhibitors*
Hypoglycemic Agents*/administration & dosage
Hypoglycemic Agents*/adverse effects
Hypoglycemic Agents*/therapeutic use
Adamantane/*analogs & derivatives
Diabetes Mellitus, Type 2/*drug therapy
Glucagon-Like Peptide 1/*analogs & derivatives
Glucagon-Like Peptide 1/*physiology
Glycoproteins/*antagonists & inhibitors
Peptides/*therapeutic use
Pyrazines/*therapeutic use
Receptors, Glucagon/*agonists
Triazoles/*therapeutic use
Venoms/*therapeutic use
Adamantane/administration & dosage ; Adamantane/adverse effects ; Adamantane/therapeutic use ; Clinical Trials as Topic ; Dipeptidyl Peptidase 4 ; Drug Administration Schedule ; Exenatide ; Glucagon-Like Peptide 1/administration & dosage ; Glucagon-Like Peptide 1/adverse effects ; Glucagon-Like Peptide 1/biosynthesis ; Glucagon-Like Peptide 1/classification ; Glucagon-Like Peptide 1/therapeutic use ; Glucagon-Like Peptide-1 Receptor ; Humans ; Liraglutide ; Nitriles ; Peptides/administration & dosage ; Peptides/adverse effects ; Pyrazines/administration & dosage ; Pyrazines/adverse effects ; Pyrrolidines ; Sitagliptin Phosphate ; Triazoles/administration & dosage ; Triazoles/adverse effects ; Venoms/administration & dosage ; Venoms/adverse effects ; Vildagliptin
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis.
Autorzy:
Griesinger G; Department of Obstetrics and Gynecology, University Clinic of Schleswig-Holstein, Campus Luebeck, Luebeck, Germany. />Diedrich K
Tarlatzis BC
Kolibianakis EM
Pokaż więcej
Źródło:
Reproductive biomedicine online [Reprod Biomed Online] 2006 Nov; Vol. 13 (5), pp. 628-38.
Typ publikacji:
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:
Fertility Agents, Female/*pharmacology
Fertilization in Vitro/*drug effects
Gonadotropin-Releasing Hormone/*analogs & derivatives
Gonadotropin-Releasing Hormone/*antagonists & inhibitors
Infertility, Female/*drug therapy
Ovulation Induction/*methods
Drug Administration Schedule ; Female ; Fertilization in Vitro/methods ; Gonadotropin-Releasing Hormone/pharmacology ; Humans ; Odds Ratio ; Ovarian Hyperstimulation Syndrome/chemically induced ; Polycystic Ovary Syndrome/drug therapy ; Randomized Controlled Trials as Topic ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
GnRH agonist versus GnRH antagonist in poor ovarian responders: a meta-analysis.
Autorzy:
Franco JG Jr; Centre for Human Reproduction Prof. Franco Junior, Av. Prof. João Fiusa, 689-CEP 14025-310, Ribeirão Preto, SP, Brazil. />Baruffi RL
Mauri AL
Petersen CG
Felipe V
Cornicelli J
Cavagna M
Oliveira JB
Pokaż więcej
Źródło:
Reproductive biomedicine online [Reprod Biomed Online] 2006 Nov; Vol. 13 (5), pp. 618-27.
Typ publikacji:
Journal Article; Meta-Analysis
MeSH Terms:
Fertility Agents, Female/*therapeutic use
Fertilization in Vitro/*drug effects
Gonadotropin-Releasing Hormone/*agonists
Gonadotropin-Releasing Hormone/*antagonists & inhibitors
Infertility, Female/*drug therapy
Ovulation Induction/*methods
Drug Administration Schedule ; Female ; Fertilization in Vitro/methods ; Humans ; Odds Ratio ; Randomized Controlled Trials as Topic ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 380

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies